Cardiotonic agents. 1. 4, 5-Dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure

JA Bristol, I Sircar, WH Moos, DB Evans…

文献索引：Bristol, James A.; Sircar, Ila; Moos, Walter H.; Evans, Dale B.; Weishaar, Ronald E. Journal of Medicinal Chemistry, 1984 , vol. 27, # 9 p. 1099 - 1101

全文：HTML全文

被引用次数: 176

摘要

The pathophysiology of heart failure consists of (1) myocardial failure and (2) the consequent systemic response to the failing myocardium that ultimately leads to peripheral congestion and edema. lP2 The fundamental defect is an impairment of ventricular function that results in an inadequate output to meet the metabolic and circulatory demands of the body. Effective therapy of heart failure is directed to enhancement of the contractile state of ...